Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
CAR-T Cell Therapy for Liver Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial tests a new treatment where a person's immune cells are modified to better fight liver cancer. It targets adults with a specific type of liver cancer that has a particular marker. The modified cells are designed to find and kill cancer cells. This marker is highly expressed in a common type of liver cancer and has been targeted in various innovative therapies for liver cancer.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service